Recently Hatfield-based Code Biotherapeutics raised $75 million to develop genetic medicines that are based on technology aimed at increasing the applicability of these types…

Hatfield-based Code Biotherapeutics has entered into a collaboration and option deal with Takeda with a potential value of $2 billion, writes John George for…